Articles From: UPDATE: At the AIG trial, lessons for Europe to Emergent BioSolutions and MorphoSys Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414


By Steve Goldstein, MarketWatch WASHINGTON (MarketWatch) -- Two former Treasury secretaries, Hank Paulson and Tim Geithner, along with former Federal Reserve Chairman Ben Bernanke, are being put in the odd position of defending themselves against the accusation that they were too tough during their rescue of the financial system.
Sign-up for UPDATE: At the AIG trial, lessons for Europe investment picks
2014/9/9
By Steven Kutz, MarketWatch Croatian Marin Cilic won his first-ever Grand Slam title on Monday by defeating Japan's Kei Nishikori 6-3, 6-3, 6-3.
Sign-up for UPDATE: Marin Cilic of Croatia wins the 2014 U.S. Open for his first-ever Grand Slam title investment picks
2014/9/8
By Steven Kutz, MarketWatch Croatian Marin Cilic won his first-ever Grand Slam title on Monday by defeating Japan's Kei Nishikori 6-3, 6-3, 6-3.
Sign-up for UPDATE: Marin Cilic of Croatia wins the 2014 U.S. Open for his first-ever Grand Slam title investment picks
2014/9/8
By Steven Kutz, MarketWatch Croatian Marin Cilic won his first-ever Grand Slam title on Monday by defeating Japan's Kei Nishikori 6-3, 6-3, 6-3.
Sign-up for UPDATE: Marin Cilic is your 2014 U.S. Open winner investment picks
2014/9/8
By Steven Kutz, MarketWatch Croatian Marin Cilic won his first-ever Grand Slam title on Monday by defeating Japan's Kei Nishikori 6-3, 6-3, 6-3.
Sign-up for Marin Cilic is your 2014 U.S. Open winner investment picks
2014/9/8
By Steven Kutz, MarketWatch For the first time in nearly a decade, a Grand Slam men's final will be played that won't include Roger Federer, Rafael Nadal or Novak Djokovic.
Sign-up for UPDATE: U.S. Open final will be without Federer, Djokovic -- and Nike investment picks
2014/9/8
By Steven Kutz, MarketWatch For the first time in nearly a decade, a Grand Slam men's final will be played that won't include Roger Federer, Rafael Nadal or Novak Djokovic.
Sign-up for UPDATE: U.S. Open final will be without Federer, Djokovic -- and Nike, Adidas investment picks
2014/10/3
By Steven Kutz, MarketWatch Most of the gloves in the Baseball Hall of Fame's permanent collection are there because of the historical significance of the players who wore them.
Sign-up for Will the next Derek Jeter wear this baseball glove? investment picks
2014/10/3
By Steven Kutz, MarketWatch Most of the gloves in the Baseball Hall of Fame's permanent collection are there because of the historical significance of the players who wore them.
Sign-up for UPDATE: Will the next Derek Jeter wear this baseball glove? investment picks
2014/10/4
By Steven Kutz, MarketWatch Most of the gloves in the Baseball Hall of Fame's permanent collection are there because of the historical significance of the players who wore them.
Sign-up for UPDATE: Is this the baseball glove of the future? investment picks
2014/10/3
By Steven Kutz, MarketWatch Most of the gloves in the Baseball Hall of Fame's permanent collection are there because of the historical significance of the players who wore them.
Sign-up for UPDATE: Is this the baseball glove of the future? investment picks
2014/10/5
By Steven Kutz, MarketWatch Most of the gloves in the Baseball Hall of Fame's permanent collection are there because of the historical significance of the players who wore them.
Sign-up for UPDATE: Is this the baseball glove of the future? investment picks
2014/10/8
By Steven Kutz, MarketWatch Most of the gloves in the Baseball Hall of Fame's permanent collection are there because of the historical significance of the players who wore them.
Sign-up for UPDATE: Is this the baseball glove of the future? investment picks
2014/10/6
By Steven Kutz, MarketWatch Most of the gloves in the Baseball Hall of Fame's permanent collection are there because of the historical significance of the players who wore them.
Sign-up for UPDATE: Is this the baseball glove of the future? investment picks
2014/10/21
By Steven Kutz, MarketWatch Most of the gloves in the Baseball Hall of Fame's permanent collection are there because of the historical significance of the players who wore them.
Sign-up for UPDATE: Is this the baseball glove of the future? investment picks
2014/10/20
By Stewart Friedman Everyone is busy trying to lead a "full" life.
Sign-up for UPDATE: If Monday morning feels so bad, here's what you can do about it investment picks
Merkerson Visits Dallas, Texas on August 14 With America's Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION, N.J. , Aug.
Sign-up for Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals investment picks
Merkerson Visits Atlanta, Georgia on October 20 With America's Diabetes Challenge: Get to Your Goals Program WHITEHOUSE STATION, N.J. , Oct.
Sign-up for Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals investment picks
Featured Presentations Highlight Data From Approved and Investigational Agents Across Amgen's Dermatology Portfolio THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Moderate-To-Severe Plaque Psoriasis Data To Be Presented At The 23rd Congress Of The European Academy Of Dermatology And Venereology investment picks
Zix Corporation (ZixCorp), (Nasdaq: ZIXI), a leader in email data protection, today announced that First State Bank of Bedias (FSBB) selected ZixOne ® to grant employees secure access to corporate email on both personal and company-owned mobile devices.
Sign-up for First State Bank of Bedias Satisfies Mobile Security Needs and Employee BYOD Demands with ZixOne investment picks
Active Defense 2.0 Analyzes and Detects Malicious Code in Memory and Helps to Pinpoint Compromised Systems in Order to Eliminate Threats FAIRFAX, Va.
Sign-up for ManTech Cyber Solutions International, Inc. Announces Advanced Visibility and Rapid Discovery of Endpoints with Active Defense™ 2.0 investment picks
MINNEAPOLIS, July 28, 2014 (GLOBE NEWSWIRE) -- Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (Nasdaq:KIPS) , announced that on July 17, 2014, Lenox Hill Hospital in New York City performed its first implant of an eSVS® Mesh.
Sign-up for Kips Bay Medical Announces the First eSVS Mesh Implant by Lenox Hill Hospital of New York investment picks
MINNEAPOLIS, Aug.
Sign-up for Kips Bay Medical Receives Updated CE Mark Approval investment picks
One of the Nation's Largest Safety Net Health Systems will Use the Market Leading Business Analytics Solutions to Measure, Predict, and Improve its Financial and Operational Performance ATLANTA , July 28, 2014 /PRNewswire/ --
Sign-up for Eskenazi Health Signs Agreement For Business Analytics And Patient Financial Solutions From Streamline Health® investment picks
2014/8/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135166&ProfileId=051205&sourceType=1 MADISON HEIGHTS, MI --
Sign-up for Creative Edge Nutrition Inc. Announces the Addition of Dr. Jonathan Lakey as the Chief Science Officer of Stem Cell & Tissue Research investment picks
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced the introduction of a new highly multiplexed gene expression panel for the nCounter ® Analysis System, the PanCancer Immune Profiling Panel.
Sign-up for NanoString Introduces Novel Gene Expression Panel for Immuno-Oncology Research investment picks
2014/10/9
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1150332&ProfileId=051205&sourceType=1 ATLANTA, GA --
Sign-up for Findit Launches URL Submission Tool for Indexing in Findit Search Results investment picks
2014/8/19
MARTINSRIED, Germany and MUNICH, Germany, Aug.
Sign-up for MorphoSys and Emergent BioSolutions Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414 investment picks
Emergent BioSolutions Inc. (NYSE: EBS) and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) today announced an agreement for the joint development and commercialization of Emergent’s preclinical bi-specific antibody, ES414, targeting prostate cancer.
Sign-up for Emergent BioSolutions and MorphoSys Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414 investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: UPDATE: At the AIG trial, lessons for Europe to Emergent BioSolutions and MorphoSys Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices